1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Refined By:
File Format:  Adobe PDF
Type:  Article
Department:  OFFICE OF THE DEPUTY PRESIDENT(RES&TECH)
Subject:  Humans

Results 1-18 of 18 (Search time: 0.016 seconds).

Issue DateTitleAuthor(s)
12018A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphataseZhou, J ; Toh, S.H.-M; Chan, Z.-L; Quah, J.Y; Chooi, J.-Y ; Tan, T.Z ; Chong, P.S.Y ; Zeng, Q ; Chng, W.-J 
21-Dec-2023A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myelomaChng, WJ ; Lonial, S; Morgan, GJ; Iida, S; Moreau, P; Kumar, SK; Twumasi-Ankrah, P; Villarreal, M; Dash, AB; Vorog, A; Zhang, X; Suryanarayan, K; Labotka, R; Dimopoulos, MA; Rajkumar, SV
32016Aberrant localization of apoptosis protease activating factor-1 in lipid raft sub-domains of diffuse large B cell lymphomasHirpara, J.L ; Loh, T ; Ng, S.B ; Chng, W.J ; Pervaiz, S 
41-Sep-2020ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia.Zhou, Jianbiao ; Yiying Quah, Jessie ; Ng, Yvonne ; Chooi, Jing-Yuan ; Hui-Min Toh, Sabrina ; Lin, Baohong; Zea Tan, Tuan ; Hosoi, Hiroki ; Osato, Motomi ; Seet, Qihui; Ooi, Lisa AG; Lindmark, Bertil; McHale, Mark; Chng, Wee-Joo 
5Jul-2017Belinostat exerts antitumor cytotoxicity through the ubiquitin-proteasome pathway in lung squamous cell carcinomaKong, L.R ; Tan, T.Z ; Ong, W.R; Bi, C; Huynh, H ; Lee, S.C ; Chng, W.J ; Eichhorn, P.J.A ; Goh, B.C 
62016Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: A role for MARCKS in acquired resistance to proteasome inhibitorsFranke, N.E; Kaspers, G.L; Assaraf, Y.G; Meerloo, J; Niewerth, D; Kessler, F.L; Poddighe, P.J; Kole, J; Smeets, S.J; Ylstra, B; Bi, C; Chng, W.J ; Horton, T.M; Menezes, R.X; Musters, R.J.P; Zweegman, S; Jansen, G; Cloos, J
72015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
82017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
92018Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimensRassidakis, G.Z; Herold, N; Myrberg, I.H; Tsesmetzis, N; Rudd, S.G; Henter, J.-I; Schaller, T; Ng, S.-B ; Chng, W.J ; Yan, B; Ng, C.H ; Ravandi, F; Andreeff, M; Kantarjian, H.M; Medeiros, L.J; Xagoraris, I; Khoury, J.D
106-Jul-2022Perspectives on the Risk-Stratified Treatment of Multiple MyelomaDavies, FE; Pawlyn, C; Usmani, SZ; San-Miguel, JF; Einsele, H; Boyle, EM; Corre, J; Auclair, D; Cho, HJ; Lonial, S; Sonneveld, P; Stewart, AK; Bergsagel, PL; Kaiser, MF; Weisel, K; Keats, JJ; Mikhael, JR; Morgan, KE; Ghobrial, IM; Orlowski, RZ; Landgren, CO; Gay, F; Caers, J; Chng, WJ ; Chari, A; Walker, BA; Kumar, SK; Costa, LJ; Anderson, KC; Morgan, GJ
116-Jul-2022Perspectives on the Risk-Stratified Treatment of Multiple MyelomaDavies, FE; Pawlyn, C; Usmani, SZ; San-Miguel, JF; Einsele, H; Boyle, EM; Corre, J; Auclair, D; Cho, HJ; Lonial, S; Sonneveld, P; Stewart, AK; Bergsagel, PL; Kaiser, MF; Weisel, K; Keats, JJ; Mikhael, JR; Morgan, KE; Ghobrial, IM; Orlowski, RZ; Landgren, CO; Gay, F; Caers, J; Chng, WJ ; Chari, A; Walker, BA; Kumar, SK; Costa, LJ; Anderson, KC; Morgan, GJ
122015Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyGupta, N; Goh, Y.T ; Min, C.-K; Lee, J.H; Kim, K; Wong, R.S.M; Chim, C.S; Hanley, M.J; Yang, H; Venkatakrishnan, K; Hui, A.-M; Esseltine, D.-L; Chng, W.J 
132016PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationTeoh P.J. ; Bi C.; Sintosebastian C.; Tay L.S. ; Fonseca R.; Chng W.J. 
142015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
152014Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsNg, S.-B ; Ohshima, K; Selvarajan, V ; Huang, G; Choo, S.-N; Miyoshi, H; Wang, S ; Chua, H.-C ; Yeoh, A.E.-J ; Quah, T.-C ; Koh, L.-P ; Tan, P.-L ; Chng, W.-J 
162016Thrombotic microangiopathy during carfilzomib use: case series in SingaporeChen, Y; Ooi, M. ; Lim, S.F; Lin, A; Lee, J; Nagarajan, C; Phipps, C; Lee, Y.S; Grigoropoulos, N.F ; Lao, Z ; Surendran, S; Teh, E.M; Goh, Y.T ; Chng, W.J ; Gopalakrishnan, S.K 
172014Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-?B regulated gene products in multiple myeloma xenograft mouse modelSiveen, K.S ; Mustafa, N ; Li, F ; Kannaiyan, R; Ahn, K.S; Kumar, A.P ; Chng, W.-J ; Sethi, G 
181-Jan-2022Vγ9Vδ2 T cells expressing a BCMA-Specific chimeric antigen receptor inhibit multiple myeloma xenograft growthZhang, X ; Ng, YY ; Du, Z ; Li, Z ; Chen, C; Xiao, L ; Chng, WJ ; Wang, S